Decision Aid Summary

Title Stage IB, II, III Non-Small Cell Lung Cancer Cisplatin plus Vinorelbine Chemotherapy after Surgery
Audience Clinicians, primarily Medical Oncologists; also, other oncology health professionals; patients, families, other members of patient's social support network. The first time a patient/caregiver uses the DA should be with the patient's cancer doctor.
Options included Taking cisplatin-vinorelbine chemotherapy after surgery.
Watchful waiting.
Year of last update or review 2017
Format paper, PDF
How to obtain Click here to view the decision aid on the developer website
Developer American Society of Clinical Oncology (ASCO)
Where was it developed? www.asco.org/guidelines, guidelines@asco.org
American Society of Clinical Oncology
US
Health condition Lung Cancer
Type of decision aid Treatment
Language English
Based on IPDAS criteria (International Patient Decision Aid Standards) this decision aid (and/or supporting materials) meets:
6 out of 7 criteria to be defined as a patient decision aid
4 out of 9 criteria to lower the risk of making a biased decision
Not applicable: other criteria for decision aids about screening or testing

Last modified: 2017-04-06.